J. T. Powell, M. J. Sweeting, P. Ulug, J. D. Blankensteijn, F. A. Lederle et al.,

D. Evar-1 and . Trialists, Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years, Br J Surg, vol.104, pp.166-178, 2017.

N. R. Smilowitz, N. Gupta, H. Ramakrishna, Y. Guo, J. S. Berger et al., Perioperative Major Adverse cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery, JAMA Cardiol, vol.2, pp.181-187, 2017.

P. J. Devereaux and D. I. Sessler, Cardiac Complications in Patients Undergoing Major Noncardiac Surgery, N Engl J Med, vol.373, pp.2258-69, 2015.

R. Patel, M. J. Sweeting, J. T. Powell, and R. M. Greenhalgh, Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial, Lancet, vol.388, pp.2366-2374, 2016.

T. Omland, J. A. De-lemos, M. S. Sabatine, C. A. Christophi, M. M. Rice et al.,

, Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease, N Engl J Med, vol.361, pp.2538-2585, 2009.

L. Buse, G. A. Bolliger, D. Seeberger, E. Kasper, J. Grapow et al., Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications, Circulation, vol.130, pp.948-57, 2014.

V. Events, ;. Devereaux, P. J. Chan, M. T. Alonso-coello, P. Walsh et al., Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators

, JAMA, vol.307, pp.2295-304, 2012.

F. Botto, P. Alonso-coello, M. Chan, J. C. Villar, D. Xavier et al., Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes

, Anesthesiology, vol.120, pp.564-78, 2014.

A. Lienhart, Y. Auroy, F. Péquignot, D. Benhamou, J. Warszawski et al., Survey of anesthesia-related mortality in France, Anesthesiology, vol.105, pp.1087-97, 2006.

K. Thygesen, J. S. Alpert, A. S. Jaffe, M. L. Simoons, B. R. Chaitman et al., Third universal definition of myocardial infarction, Circulation, vol.126, pp.2020-2055, 2012.

. Poise-study-group, P. J. Devereaux, H. Yang, S. Yusuf, G. Guyatt et al., Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial, Lancet, vol.371, pp.1839-1886, 2008.

, Société Française d'Anesthésie et de Réanimation, Société Française de Cardiologie. Prise en charge du coronarien qui doit être opéré en chirurgie non cardiaque

, Recommandations Formalisées d'Experts, 2010.

C. J. Railton, J. Wolpin, J. Lam-mcculloch, and S. E. Belo, Renin-angiotensin blockade is associated with increased mortality after vascular surgery, Can J Anaesth, vol.57, pp.736-780, 2010.

M. E. Jørgensen, M. A. Hlatky, L. Køber, R. D. Sanders, C. Torp-pedersen et al., Andersson C. ?-Blocker-Associated Risks in Patients With Uncomplicated Hypertension Undergoing Noncardiac Surgery, JAMA Intern Med, vol.17, pp.1923-1954, 2015.

J. A. Beckman and M. A. Creager, The nonlipid effects of statins on endothelial function, Trends Cardiovasc Med, vol.16, pp.156-62, 2006.

D. Martino, R. R. Eldrup-jorgensen, J. Nolan, B. W. Stone, D. H. Adams et al.,

, Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery, J Vasc Surg, vol.59, pp.1615-1636, 2014.

L. Manach, Y. , I. Esteves, C. Bertrand, M. Goarin et al., Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery, Anesthesiology, vol.114, pp.98-104, 2011.

J. Guay and E. A. Ochroch, Effects of adding statins before surgery on mortality and major morbidity: a meta-analysis, J Cardiothorac Vasc Anesth, vol.28, pp.255-66, 2014.

C. Baigent, L. Blackwell, J. Emberson, L. E. Holland, C. Reith et al., Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Cholesterol Treatment Trialists' (CTT) Collaboration, vol.376, pp.1670-81, 2010.

. Esc/eas, Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and

, EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR), European Atherosclerosis Society

, Atherosclerosis, vol.253, pp.281-344, 2016.

F. Rodriguez, D. J. Maron, J. W. Knowles, S. S. Virani, S. Lin et al., Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease, JAMA Cardiol, vol.2, pp.47-54, 2017.

T. R. Pedersen, O. Faergeman, J. J. Kastelein, A. G. Olsson, M. J. Tikkanen et al., Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial, JAMA, vol.294, pp.2437-2482, 2005.

R. A. Ribeiro, P. K. Ziegelmann, B. B. Duncan, S. F. Stella, C. Da et al., Impact of statin dose on major cardiovascular events: a mixed treatment comparison meta-analysis involving more than 175,000 patients, Int J Cardiol, vol.166, pp.431-440, 2013.

S. V. Rao, J. G. Jollis, R. A. Harrington, C. B. Granger, L. K. Newby et al., Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes, JAMA, vol.292, pp.1555-62, 2004.

A. Turan, D. Yang, A. Bonilla, A. Shiba, D. I. Sessler et al., Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery, Can J Anaesth, vol.60, pp.761-70, 2013.

L. G. Glance, A. W. Dick, D. B. Mukamel, F. J. Fleming, R. A. Zollo et al., Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery, Anesthesiology, vol.114, pp.283-92, 2011.

L. Manach, Y. Perel, A. Coriat, P. Godet, G. Bertrand et al., Early and delayed myocardial infarction after abdominal aortic surgery, Anesthesiology, vol.102, pp.885-91, 2005.

G. Godet, B. Riou, M. Bertrand, M. H. Fléron, J. P. Goarin et al., Does preoperative coronary angioplasty improve perioperative cardiac outcome?, Anesthesiology, vol.102, pp.739-785, 2005.

L. Manach, Y. Godet, G. Coriat, P. Martinon, C. Bertrand et al., The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery, Anesth Analg, vol.104, pp.1326-1359, 2007.

A. Foucrier, R. Rodseth, M. Aissaoui, C. Ibanes, J. P. Goarin et al., The long-term impact of early cardiovascular therapy intensification for postoperative troponin elevation after major vascular surgery, Anesth Analg, vol.119, pp.1053-63, 2014.

T. H. Lee, E. R. Marcantonio, C. M. Mangione, E. J. Thomas, C. A. Polanczyk et al., Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery, Circulation, vol.100, pp.1043-1052, 1999.

E. Boersma, M. D. Kertai, O. Schouten, J. J. Bax, P. Noordzij et al., Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index

, Am J Med, vol.118, pp.1134-1175, 2005.

K. E. Kip, K. Hollabaugh, O. C. Marroquin, and D. O. Williams, The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention, J Am Coll Cardiol, vol.51, pp.701-708, 2008.

A. L. Shroyer, B. Hattler, T. H. Wagner, J. F. Collins, J. H. Baltz et al., Veterans Affairs ROOBY-FS Group. FiveYear Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass, N Engl J Med, vol.377, pp.623-632, 2017.

G. Gargiulo, S. Windecker, B. R. Da-costa, F. Feres, M. K. Hong et al., Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials, BMJ, vol.355, p.5483, 2016.

L. Manach, Y. Coriat, P. Collard, C. D. Riedel, and B. , Statin Therapy within the Perioperative Period, Anesthesiology, vol.108, pp.1141-1147, 2008.

A. O. Molnar, S. G. Coca, P. J. Devereaux, A. K. Jain, A. Kitchlu et al., Statin Use Associates with a Lower Incidence of Acute Kidney Injury after Major Elective Surgery, J Am Soc Nephrol, vol.22, pp.939-985, 2011.

O. Berwanger, L. Manach, Y. Suzumura, E. A. Biccard, B. Srinathan et al., Devereaux PJ; VISION Investigators. Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study, Eur Heart J, vol.37, pp.177-85, 2016.

L. Manach, Y. Collins, G. S. Ibanez, C. Goarin, J. P. Coriat et al., Impact of Perioperative Bleeding on the Protective Effect of ?-Blockers during Infrarenal Aortic Reconstruction, Anesthesiology, vol.117, pp.1203-1214, 2012.

M. E. Jørgensen, M. A. Hlatky, L. Køber, R. D. Sanders, C. Torp-pedersen et al., Andersson C. ?-Blocker-Associated Risks in Patients With Uncomplicated Hypertension Undergoing Noncardiac Surgery, JAMA Intern Med, vol.175, pp.1923-1954, 2015.

W. S. Beattie, D. N. Wijeysundera, K. Karkouti, S. Mccluskey, G. Tait et al., Acute surgical anemia influences the cardioprotective effects of beta-blockade : a single-center, propensity-matched cohort study, Anesthesiology, vol.112, pp.25-33, 2010.

F. Hovaguimian and P. S. Myles, Restrictive versus Liberal Transfusion Strategy in the Perioperative and Acute Care Settings: A Context-specific Systematic Review and Metaanalysis of Randomized Controlled Trials, Anesthesiology, vol.125, pp.46-61, 2016.

S. Kheterpal, O. Khodaparast, A. Shanks, M. O'reilly, and K. K. Tremper, Chronic angiotensinconverting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery, J Cardiothorac Vasc Anesth, vol.22, pp.180-186, 2008.

S. Kheterpal, M. O'reilly, M. J. Englesbe, A. L. Rosenberg, A. M. Shanks et al., Preoperative and intraoperative predictors of cardiac adverse events after general, vascular, and urological surgery, Anesthesiology, vol.110, pp.58-66, 2009.

M. Bertrand, G. Godet, K. Meersschaert, L. Brun, E. Salcedo et al., Should the angiotensin II antagonists be discontinued before surgery?, Anesth Analg, vol.92, pp.26-30, 2001.

R. S. Twersky, V. Goel, P. Narayan, and J. Weedon, The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients, Anesth Analg, vol.118, pp.938-982, 2014.

S. Paravastu, R. Jayarajasingam, R. Cottam, S. J. Palfreyman, J. A. Michaels et al., Endovascular repair of abdominal aortic aneurysm, The Cochrane Collaboration, éditeur. Cochrane Database of Systematic Reviews

U. K. Chichester,